Akums Drugs and Pharmaceutical (AKUMS) — Free Cash Flow Generation Index
Akums Drugs and Pharmaceutical (AKUMS) has a Free Cash Flow Generation Index of 0.90x as of September 2025. Free cash flow of Rs10.40 Billion represents 1% of operating cash flow (Rs11.52 Billion). Explore AKUMS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Akums Drugs and Pharmaceutical Free Cash Flow Generation Index (2022–2026)
Historical FCF Generation Index trend for Akums Drugs and Pharmaceutical across 5 annual periods. For the full cash flow conversion analysis, see AKUMS cash generation efficiency.
Annual Free Cash Flow Generation for Akums Drugs and Pharmaceutical (2022–2026)
Year-by-year Free Cash Flow Generation Index for Akums Drugs and Pharmaceutical. Check AKUMS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.81x | Rs9.80 Billion | Rs12.11 Billion | Rs2.31 Billion | ▲ +95.3% |
| 2025 | 0.41x | Rs1.93 Billion | Rs4.65 Billion | Rs2.72 Billion | ▲ +10.6% |
| 2024 | 0.38x | Rs1.87 Billion | Rs4.98 Billion | Rs3.11 Billion | ▲ +143.5% |
| 2023 | -0.86x | Rs-1.52 Billion | Rs1.77 Billion | Rs3.29 Billion | ▲ +87.8% |
| 2022 | -7.09x | Rs-2.26 Billion | Rs318.54 Million | Rs2.58 Billion | — |